{
    "clinical_study": {
        "@rank": "11677", 
        "arm_group": [
            {
                "arm_group_label": "CAD, OMEGA 3", 
                "arm_group_type": "Active Comparator", 
                "description": "patients with CAD who receive 4 gr/day omega 3 in the form of 4 softgels each of them contains 1000 mg omega 3 and a softgel contains placebo of vitamin E"
            }, 
            {
                "arm_group_label": "CAD, omega 3 and vitamin E", 
                "arm_group_type": "Active Comparator", 
                "description": "patients with CAD who receive 4 gr/day omega 3 in the form of 4 softgels each of them contains 1000 mg omega 3 and a softgel contains 400 IU vitamin E"
            }, 
            {
                "arm_group_label": "CAD, placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "patients with CAD who receive 4 softgels/day each of them contains placebo of omega 3 and a softgel/day contains placebo of vitamin E"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to determine the effects of omega 3 supplementation and  its\n      concurrent supplementation with vitamin E  on the serum levels of antioxidant enzymes and\n      the expressions of the PGC-1a, h TERT, FOXO1, FOXO3a , SIRT1,SIRT3, SIRT6 genes in PBMC\n      cells in the patients with coronary artery disease"
        }, 
        "brief_title": "The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -\n\n        literate, willingness to participation, CAD patients 45- 65 years old, body mass index<\n        30, avoidance of dietary supplements, vitamins and herbal products at least 3 months\n        before and throughout the intervention, willing to maintain body weight during the study\n\n        Exclusion Criteria:\n\n          -  people who have used vitamin E or omega 3 supplements in last 3 months, having\n             chronic renal disease ,cancer, Hepatobilliary diseases, hematological disorders,\n             hypo- or hyperthyroidism, diabetes, treatment with PPAR-gamma agonists or\n             Thiazolidinediones, Smokers"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011906", 
            "org_study_id": "95983"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CAD, OMEGA 3", 
                    "CAD, omega 3 and vitamin E"
                ], 
                "intervention_name": "omega 3", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "CAD, omega 3 and vitamin E", 
                "intervention_name": "vitamin E", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "CAD, placebo", 
                "intervention_name": "placebo of omega 3", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "CAD, OMEGA 3", 
                    "CAD, placebo"
                ], 
                "intervention_name": "placebo of vitamin E", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "antioxidant enzymes", 
            "omega 3", 
            "vitamin E", 
            "CAD", 
            "Sirtuins", 
            "FOXOs"
        ], 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Tehran University of Medical Sciences"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "3", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "serum total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum HDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum triglycerides level", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum LDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum insulin", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum Hs-CRP", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum gluthatione peroxidase", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum catalase", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum superoxide dismutase", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "serum total antioxidant capacity", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011906"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "gene expression of SIRT1", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of SIRT3", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of SIRT6", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of PGC-1a", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of FOXO3a", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of FOXO1", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }, 
            {
                "measure": "gene expression of h TERT", 
                "safety_issue": "No", 
                "time_frame": "change from baseline at 2 months"
            }
        ], 
        "source": "Tehran University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tehran University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}